Immunotherapy is redefining how doctors treat women diagnosed with stage 4 cervical cancer – offering hope where traditional treatments often fall short. According to global cancer statistics provided ...

The rate of young women dying from cervical cancer in the UK has fallen drastically since the nationwide rollout of the HPV ...

Data analysis reveals a stable, cross-cohort female cancer mortality excess at ages 35-60, contrasting with female advantages in cardiovascular and external-cause mortality. Breast cancer drives the ...

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Children who are vaccinated for HPV at age 12-13 have close to zero risk of dying from cervical cancer before they are 30, a study estimates.